<unk>  (brand name Zontivity, formerly known as SCH 530348) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine, discovered by Schering-Plough and developed by Merck & Co.
Vorapaxar
Sesquimustard
Pretomanid
Vagisil
Tezacaftor
Patiromer
Tasimelteon
Enarodustat